No , the Conference call yesterday explaining the AIDS PDUFA date letter from the FDA had only minor things that could be provided real soon and it had nothing to do with the trials or efficacy . Secondly, he gave firm dates on the results for the Covid trials. It went down early yesterday because the headline was Cytodyn gets refusal to file letter from FDA without explaining it was only a minor hiccup and delay that the CEO explaining after hours yesterday at 4pm. However, the present run up from where it was in January , which was .50 cents , is entirely CoVid related. The 7 straight positive days leading up to the short attack on June 30th was in anticipation of the trials being done sooner than now. The fluctuation between July 1 and today is the short attack and not having the results sooner. The answer is right around the corner. If you weren’t in on CyDy , yesterday ‘s $2.86 stock price after the drop, would have been a good time to buy , because you are unlikely to see that price that low again.Up 30% today.
Not sure if it was based on anything besides a rebound off previous days steep drop.